About PleoPharma
PleoPharma is a private company based in Phoenixville, Pennsylvania. It has reported $22,902,252 raised in four offerings on Form D since February 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Aug 10, 2026 | $5,500,000of $15.0M target | 11 | $500K | DebtRule 506(b) | Form D ↗ |
| Jun 23, 2025 | Aug 8, 2025 | $6,150,000of $36.2M target | 9 | $683K | EquityRule 506(b) | Form D ↗ |
| May 2, 2022 | May 6, 2022 | $11,122,252of $16.1M target | 47 | $236K | EquityRule 506(b) | Form D ↗ |
| Jan 27, 2020 | Feb 4, 2020 | $130,000target not set | 1 | $130K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $22,902,252 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PleoPharma's Form D filed Aug 10, 2026.
KT
Kyle Tomlin
Director
GC
SH
JC
Jay Constantine
Chief Medical Officer, Co-Founder and Director
MT
McInerney Timothy
Director
TP
Thomas Poche
Executive officer
DC
RF
PB
Paul Bisaro
Director
TT
Tommy Thompson
Director
KM
BS
Earlier filings also listed Daniel Cartwritght (executive officer, last listed May 2022).
Sources
- SECPLEOPHARMA, INC. filing history
- CompanyPhase 3 trial announcement
- CompanyManagement team
- CompanyBoard of directors